Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Journal of Neuro-Oncology|January 3, 2025
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomasSanghee Lim, Nathan H Clarke, Sara L Maloney, et al.The American Journal of Surgical Pathology|February 19, 2021
Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular HeterogeneityKathryn L Eschbacher, Cristiane M Ida, Derek R Johnson, et al.Communications Medicine|February 10, 2026
Assessments of social vulnerability on central nervous system cancer disparities in the United StatesDavid J Fei-Zhang, Salim C Lutfallah, Joshua Mensah, et al.Neurology|July 31, 2023
Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center ExperienceBryan J Neth, Aditya Raghunathan, Sani H Kizilbash, et al.Journal of Neurosurgery|April 4, 2020
Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experienceSalomon Cohen-Cohen, Desmond A Brown, Benjamin T Himes, et al.Journal of Neuro-Oncology|May 18, 2022
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade gliomaWilliam G Breen, Ryan S Youland, Sharmila Giri, et al.Journal of Neuro-Oncology|October 14, 2025
Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarkerJacob Guzzino, David J Crompton, Shubhi Agarwal, et al.Neuro-Oncology Advances|March 29, 2024
Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysisWilliam G Breen, Connie S Geno, Mark R Waddle, et al.Journal of Neuro-Oncology|March 6, 2025
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysisBryan J Neth, Robert M Kraft, Kathryn L Eschbacher, et al.Neuro-Oncology|January 9, 2025
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-OncologyCecile Riviere-Cazaux, Michael B Keough, Jeffrey A Zuccato, et al.Pageof 6